NewTimeSpace News,Singapore-listed company Mary Chia announced on March 9 the completion of the proposed new shares subscription. The company allotted and issued 5.7143 million new shares to the subscriber at a subscription price of S$0.035 per share, bringing the company's total share capital up to 334 million shares accordingly.
NewTimeSpace News,Singapore Exchange announced on March 10 that Canacol Energy Ltd. has completed the first subsequent advance under its Debtor-in-Possession (DIP) financing. All precedent conditions set out in the DIP Financing Commitment Letter have been satisfied for this advance, and the relevant financing arrangement has previously obtained approvals from the Canadian and U.S. courts.
MIRXES-B (02629.HK), which holds the world’s only approved gastric cancer early screening IVD product, has recently encountered a capital winter. As of March 9, 2026, the share price stood at HK$14.81, down over 36% from its IPO price and 66.37% YTD, with its market capitalization shrinking to HK$4.417 billion. Although the core business gross margin rose to 67.6% in H1 2025, the company has yet to escape its loss-making predicament, with cumulative losses exceeding US$200 million from 2022 to 2024. In early 2026, it raised HK$711 million through a placement and partnered with XtalPi to create an "AI + Early Screening" closed loop, while cornerstone investors committed to a lock-up to bolster market confidence.
NewTimeSpace: CR Construction Group Holdings Limited (01582.HK) announced that its indirectly wholly-owned subsidiary, CR Construction Co., Ltd., has signed a letter of acceptance in respect of the main construction works contract for the development of a logistics centre in Kwai Chung, New Territories, Hong Kong, with a contract value of approximately HK$3.6 billion. The Group will act as the main contractor for the project.
NewTimeSpace: HBM Holdings Limited (02142.HK) announced that the Investigational New Drug (IND) application for HBM7575 (also known as SKB575), a long‑acting bispecific antibody targeting TSLP and an undisclosed target for the treatment of atopic dermatitis, has been approved by the National Medical Products Administration (NMPA) of China.
NewTimeSpace News,On March 9, OKP Holdings Limited, a mainboard-listed company in Singapore, announced that it has secured a commuter infrastructure contract worth approximately S$87.3 million from the Land Transport Authority of Singapore (LTA). The contract covers the construction of facilities surrounding upcoming stations on the Jurong Region Line (JRL), with a term of 60 months effective from February 2026.
NewTimeSpace News,On March 9, Singapore-listed Seatrium Limited announced that it has been awarded the 8th Floating Storage and Regasification Unit (FSRU) conversion contract by its long-term client Karpowership, and has successfully delivered the FSRU LNGT Powership Oceania at the same time.
NewTimeSpace News,On March 9, Addvalue Technologies Ltd announced via a regulatory filing that the Group has secured new orders worth approximately US$3.7 million through its core growth business – space connectivity-related operations, covering multiple Inter-Satellite Data Relay System (IDRS) terminals. The delivery of these orders is expected to be substantially completed within the next 12 months.
NewTimeSpace News,On March 9, AJJ MEDTECH HOLDINGS LIMITED, a Singapore-listed enterprise, announced that its wholly-owned subsidiary AJJ Healthcare Management Pte. Ltd. has signed a four-year supply contract for biodegradable medical consumables valued at approximately S$3 million with a network of Singaporean healthcare institutions, effective June 1.
As the "Subscription King" of the 2025 Hong Kong IPOs, Chery Automobile (09973.HK) has faced a capital market cold shoulder less than six months after its listing. As of March 6, 2026, its share price hit a new low of HK$25, down approximately 18.70% from its HK$30.75 offer price, with total market cap shrinking to HK$145.2 billion.Significant Sales Decline: 2026 started poorly, with cumulative sales for Jan-Feb down 12.5%. Aside from the core Chery brand, Exeed, Jetour, and iCAR all saw major slowdowns, while the Huawei-partnered Luxeed brand saw February sales plunge by 90.6%.Pressure on Export Dividends: Turmoil in the Middle East may pose a direct blow to a core overseas market that accounts for nearly 18% of Chery's exports.
NewTimeSpace News,March 5 - GS HOLDINGS LIMITED, a Singapore-listed company, announced via a notice that it has completed the acquisition of all the issued and fully paid-up share capital of Dyspatchr Pte. Ltd.. On the same day, the company completed the placement and issue of a total of 36.5334 million new shares, including consideration shares and retention incentive shares.
NewTimeSpace News,March 5 - LPH, a subsidiary of Singapore Mainboard-listed Rex, announced via a press release that the connection work of the Mobile Offshore Production Unit (MOPU) and Floating Storage and Offloading unit (FSO) at the Sèmè Oilfield in Benin has been fully completed. The commissioning of the production system is progressing in an orderly manner, and regular production is expected to start after the completion of optimization tests in the coming days.
NewTimeSpace News,According to an announcement released by the Singapore Exchange on March 5, Wipro, an India-based AI-driven technology services and consulting company, announced the appointment of Ms. Laura Marie Miller as a director of the company. Her five-year term will take effect on April 1, 2026, subject to shareholder approval.
On March 5, 2026, IFBH (06603.HK), the "first stock of coconut water," saw its share price close up 11.06% at HK$11.65 after officially denying the "added sugar" allegations. Despite the rebound, nearly HK$10 billion of the company's market value has evaporated within eight months of listing, a drop of over 70% from its post-IPO peak. In 2025, IFBH faced core financial and operational pressures, with expected net profit down 27%-32%, operating cash flow shrinking by 70.5%, and accounts receivable surging by 173%. The company is highly dependent on the single brand "if" (94.5% of revenue) and the Mainland China market (90.4%).
NewTimeSpace:SSY Group Limited (02005.HK) announced that it has obtained the drug production registration approval from the National Medical Products Administration (NMPA) for Calcium Levofolinate for Injection (25mg). The product is classified as a Class 3 chemical drug and is deemed to have passed the consistency evaluation. It is mainly used for the treatment of gastric cancer and colorectal cancer.
NewTimeSpace: Shanghai Henlius Biotech, Inc. (02696.HK) announced a voluntary announcement that the Phase 1 clinical trial application of HLX97, a self-developed KAT6A/B small-molecule inhibitor, for the treatment of advanced/metastatic solid tumors has been approved by the National Medical Products Administration (NMPA) of China. As of the date of this announcement, no similar products have been approved for marketing worldwide.
